Friday, September 17, 2010

EPGL - Stock Surges On Record Volume




Investors were scrambling to pick up shares of EPGL today sending the stock higher and helping it post a record volume day. The news released after the close of trade yesterday was the reason for the demand for EPGL stock and I think this will continue for quite a while.

This is a stock that ran last year at precisely the same time and at the same price to $.0024 a share. With the company addressing their debt issues, the rally this time could have more staying power.



EP Global Communications, Inc. Opens Health Sciences Division for Marketing of Biotechnology Products and Services Worldwide

Company Taps into Network of Resources in Medicine and Science to Address Market Worth Approximately $85 Billion Annually

JOHNSTOWN, Pa., Sep 16, 2010 (BUSINESS WIRE) -- EP Global Communications, Inc. (EPGL), (the Company), (Pink Sheets: EPGL), (www.eparent.com), the parent company of Exceptional Parent (EP) magazine, is pleased to announce that the new EP Health Sciences Division of the company is operational. The EP Health Sciences Division is utilizing the substantial network of resources that EPGL has established in both the fields of medicine and science over 40 years of existence.

"We are working with Dr. Norman Marcus and his innovative therapy coupled with the Muscle Pain Detection Device which has had significant beneficial results for many patients dealing with significant back pain. This intervention therapy addresses a market which has been estimated to be $85 billion in size and Dr. Marcus' approach can help potentially millions of people experience relief from chronic pain for the first time," said Joe Valenzano, the CEO of EPGL. This marks a significant expanded direction for EPGL. Valenzano went on further to say that, "Dr. Marcus treated my condition, diagnosed as compressed or bulging discs in C-2 through C-7, with his intervention therapy and the MPDD and I am completely pain free today - after living with constant pain for over thirteen years."

Dr. Marcus will be speaking on pain and pain management at the upcoming World Congress on Disabilities (http://thewcd.org) in Dallas, Texas, November 18-19, 2010.

"Our goal is to help increase awareness of the MPDD and Dr. Marcus' Therapy to the institutions that need it the most urgently due to the vast numbers of potential patients afflicted with pain," Valenzano explained. "Our goal is to have this embraced by the medical community over the next several years via expanded knowledge, awareness and education."

EPGL is also continuing work on developing a Resource Guide for the Nutraceutical Community, working collaboratively with Stephan DeFelice, MD. "We hope to have this product available in early 2011," said Valenzano. The product itself will increase education and awareness and highlight the many issues faced by those utilizing Nutraceuticals in combination with Rx Medications and when such use may not be in the patient's best interests.

About EP Global Communications, Inc.

EP Global Communications, Inc., parent company of Exceptional Parent (EP) magazine, is a 40-year-old, award-winning, multi-media publishing and communications company, providing timely and indispensable resources and information to families and professionals caring for the needs of children and adults with disabilities and special health care needs, including families in the U.S. Military.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

SOURCE: EP Global Communications, Inc.

No comments: